Japan CD31 Antibody Market was valued at USD 0.05 Billion in 2022 and is projected to reach USD 0.08 Billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030.
The Japan CD31 antibody market is segmented based on various applications, each of which plays a critical role in advancing medical and scientific research. One prominent application is in cancer research, where CD31 antibodies are utilized to study angiogenesis—the formation of new blood vessels within tumors. This process is essential for understanding tumor growth and metastasis. By targeting CD31, a key marker for endothelial cells, researchers can gain insights into the mechanisms of cancer progression and evaluate the effectiveness of anti-angiogenic therapies. This application has a significant impact on developing novel treatments and improving patient outcomes in oncology.
Another important application of CD31 antibodies is in cardiovascular research. These antibodies are used to investigate vascular endothelial function and pathology, which are crucial for understanding various heart diseases and vascular disorders. CD31 antibodies help in analyzing endothelial cell interactions, identifying dysfunctions, and studying the progression of conditions like atherosclerosis and hypertension. This research is pivotal for developing new therapeutic strategies and improving diagnostic methods in cardiovascular medicine.
Â
Get an In-Depth Research Analysis of the Japan CD31 Antibody Market Size And Forecast [2025-2032]
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan CD31 Antibody Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan CD31 Antibody Market
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Based on Types the Market is categorized into Below types that held the largest CD31 Antibody market share In 2023.
Monoclonal
Polyclonal
Japan (United States, Japan and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ CD31 Antibody Market Research Analysis
1. Introduction of the Japan CD31 Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan CD31 Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan CD31 Antibody Market, By Type
6. Japan CD31 Antibody Market, By Application
7. Japan CD31 Antibody Market, By Geography
Japan
Europe
Asia Pacific
Rest of the World
8. Japan CD31 Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Japan Research and Consulting firm servicing over 5000+ Japan clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/